Catalyst
Analyst ratings show a consensus of one Buy recommendation, indicating institutional optimism for CTRA.
Fund flows show positive net inflows in large and extra-large orders, suggesting strong capital interest.
Risk
Recent technical indicators such as the Long Lower Shadow and MACD Death Cross on January 5 suggest bearish bias for CTRA.
Fundamental factors like PB-ROE and Revenue-MV are flagged as negative, indicating valuation and profitability concerns.
Generated at20:5901/15/2026by
Aime